 | | |
|
|
|
Largest losses
Ranked by net income from continuing operations.
|
1 |
Sepracor |
-$295.7 |
-117.5 |
|
2 |
Millennium Pharmaceuticals |
-$252.3 |
47.8 |
|
3 |
American Tower Corp. |
-$239.2 |
9.7 |
|
4 |
3Com Corp. |
-$188.1 |
54.5 |
|
5 |
Vertex Pharmaceuticals |
-$166.2 |
37.6 |
|
6 |
Oscient Pharmaceuticals |
-$93.5 |
-218.1 |
|
7 |
Alkermes |
-$84.1 |
25.3 |
|
8 |
Indevus Pharmaceuticals |
-$77.4 |
-101.3 |
|
9 |
Aspen Technology |
-$77.2 |
-3,611.6 |
|
10 |
Cubist Pharmaceuticals |
-$76.5 |
33.5 |
SOURCE: Standard&Poor's Compustat
|
|
|
|
|
